Treatment of chronic hepatitis B with lamivudine in renal transplant recipients

International Journal of Artificial Organs

Volumn 30, Issue 4, 2007, Pages 308-314

  Zubkin, Mikhail L ^a   Balakirev, E ^a   Chervinko, V ^a   Baranova, F ^a   Zolotarevsky, V ^a   Bakulin, I ^a   Stahanova, V ^a   Stanke, A ^a   Stenina, I ^a   Kovalchuk, A ^a   Novozhenov, V ^a  

^a Moscow Nephrology Center   (Russian Federation)

Author keywords

Hepatitis B; Lamivudine; Renal transplantation

Indexed keywords

BODY FLUIDS;

ACTIVITY INDEX; AMINOTRANSFERASE; ANTIVIRAL THERAPY; CHRONIC HEPATITIS; CONDITION; HEPATITIS B; LAMIVUDINE; NORMALISATION; RENAL TRANSPLANT RECIPIENTS; RENAL TRANSPLANTATION;

PATIENT TREATMENT;

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CREATININE; CYCLOSPORIN A; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; VIRUS DNA; VIRUS RNA;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ANTIVIRAL THERAPY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; RELAPSE; SUPERINFECTION; TREATMENT DURATION; VIREMIA; VIRUS LOAD;

EID: 34250666682     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000405     Document Type: Article

References (29)

1. Parfrey PS, Farge D, Forbes RD, et al. Chronic hepatitis in end-stage renal disease: Comparison of HBsAg-negative and HBsAg-positive patients. Kidney Int 1985; 28: 959-67.
2. Fabrizi F, Martin P, Ponticelli C. Hepatitis B virus and renal transplantation. Nephron 2002; 90: 241-51.
3. Rao VK, Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 1996; 62: 1765-9.
4. Younossi MZ, Braun EW, Protiva DA, et al. Chronic viral hepatitis in renal transplant recipients with allografts functioning for more 20 years. Transplantation 1999; 67: 272-5.
5. Pirson Y, Alexandre GP, van Yperserle de Strihou C. Long-term effect of HBs antigenemia on patient survival after renal transplantation. N Engl J Med 1977; 296: 194-6.
6. White AG, Kumar MS, Strannegard O, et al. Renal transplantation in hepatitis B surface antigen-positive patients. Transplant Proc 1987; 19: 2150-2.
7. Mathurin P, Mouquet C, Poynard T, et al. Impact of hepatitis B and C on kidney transplantation outcome. Hepatology 1999; 29: 257-63.
8. Debure A, Degos F, Pol S, et al. Liver disease and hepatic complications infection in renal transplant patients. Adv Nephrol 1988; 17: 375-400.
9. Magnone M, Holley JL, Shapiro R, et al. Interferon-α-induced acute renal allograft rejection. Transplantation 1995; 59: 1068-70.
10. Rostaing L., Rumean JL, Cisterne J, et al. Liver histology in renal transplant patients after more than 10 years of hepatitis C virus infection. Transplant Proc 1996; 28: 2836-37.
11. Fontaine H, Thiers V, Chertin Y, et al. HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. Transplantation 2000; 69: 2090-4.
12. Lewandowska D, Durlik M, Kukula K, et al. Treatment of chronic hepatitis B with lamivudine in renal allograft recipients. Transplant Proc 2000; 32: 1369-70.
13. Chan TM, Fang GX, Tang CS, et al. Pre-emptive lamivudine therapy based on HBV DNA in HBsAg-positive kidney allograft recipients. Hepatology 2002; 36: 1246-52.
14. Mosconi G, Scolari MP, Manna C, et al. Lamivudine in recurrent hepatitis B after renal transplantation. Transplant Proc 2001; 33: 1873-4.
15. Han DJ, Kim TH, Park SK, et al. Results on preemptive or prophylactic treatment of lamviduine in HBsAg + renal allograft recipients: Comparison with salvage treatment after hepatic dysfunction with HBV recurrence. Transplantation 2001; 71: 387-94.
16. Park S-K, Yang WS, Lee YS, et al. Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine. Nephrol Dial Transplant 2001; 16: 2222-8.
17. Knodell RG, Ishak KG, Dlack WS, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 4:431.
18. Fairley CK, Mijch A, Gust ID, et al. The increased risk of fatal liver disease in renal transplant patient who are hepatitis B e antigen and/or HBV DNA positive. Transplantation 1991; 52: 497-500.
19. Dienstag J, Perillo R, Schiff E, et al. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657.
20. Rostaing L, Henry S, Cisterne J-M, et al. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation. Transplantation 1997; 64: 1624-7.
21. Jung YO, Lee YS, Yang WS, et al. Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. Transplantation 1998; 66: 733-7.
22. Goffin E, Horsmans Y, Cornu C, et al. Lamivudine inhibits hepatitis B virus replication in kidney graft recipients. Transplantation 1999; 12: 322-7.
23. Antoine C, Landau A, Menoyo V, et al. Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B. Transplant Proc 2000; 32: 384-5.
24. Lee W-C, Wu M-J, Cheng C-H, et al. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis 2001; 38: 1074-81.
25. Kletzmayr J, Watschinger B, Muller C, et al. Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients. Transplantation 2000; 70:1404-7.
26. Mouquet C, Bernard B, Poynard T, et al. Chronic hepatitis B treatment with lamivudine in kidney transplant patients. Transplant Proc 2000; 32: 2762.
27. Fabrizi F, Dulai G, Dixit V, et al. Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials. Transplantation 2004; 77: 859-64.
28. Perrillo RP. Hepatitis B and renal transplantation: securing the sword of Damocles. Hepatology 2002; 36: 1041-5.
29. Fontana RJ. Renal transplantation in HBsAg+ patients. J Clin Gastroenterol 2003; 37: 9-11.